Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Pneumocystic carinii pneumonia


See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment


Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Atovaquone
Trade Name
(Manufacturer Name)
Mepron®
(Glaxo Wellcome Inc.)
Indication
The FDA has approved this product to be used in this manner.
For the acute oral treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in patients who are intolerant to trimethoprim-sulfamethoxazole. Prevention of PCP in patients who are intolerant to trimethoprim-sulfamethoxazole.
More Information about this product Drug Information Portal

Generic Name Pentamidine isethionate
Trade Name
(Manufacturer Name)
Nebupent®
(APP Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Trimetrexate glucuronate
Trade Name
(Manufacturer Name)
Neutrexin®
(Medimmune Oncology, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Concurrent leucovorin administration as an alternative therapy for the treatment of moderate to severe PCP in immunocompromised patients who are intolerant of, or are refractory to, trimethoprim sulfamethoxazole.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Pentamidine isethionate
Trade Name
(Manufacturer Name)
Pentam 300®
(APP Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of Pneumocystis carinii pneumonia.
More Information about this product Drug Information Portal
Medline Plus Health Information